Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
13
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bollinger Lisa | Director | 12 | $0 | $0 | 2026-09-03 |
| Dambkowski Carl | Chief Medical Officer | 102 | $0 | $14.41M | 2026-09-03 |
| Fox Jennifer A. | Director | 11 | $0 | $0 | 2026-09-03 |
| Fairmount Funds Management LLC | Director | 27 | $50.00M | $0 | 2026-09-03 |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | 66 | $0 | $37.96M | 2026-09-03 |
| McKenna Mark C. | Director | 17 | $990.8K | $0 | 2026-09-03 |
| Shah Nimish P | Director | 20 | $44.75M | $0 | 2026-09-03 |
| Henderson Jane | Chief Financial Officer | 35 | $0 | $2.38M | 2026-09-03 |
| JONES WILLIAM A JR | Director | 11 | $0 | $0 | 2026-09-03 |
| Fairmount Healthcare Fund II L.P. | Director | 4 | $0 | $0 | 2026-08-07 |
| Kiselak Tomas | Director | 1 | $0 | $0 | 2026-06-09 |
| Harwin Peter Evan | Director | 10 | $0 | $133.53M | 2026-01-22 |
| Gottesdiener Andrew | Director | 3 | $0 | $0 | 2025-06-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 365,853 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 6,743,321 | $135.11 | $911.09M | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 47,758 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | $0 | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 387,012 | — | $0 | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 253,016 | — | $0 | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 357,036 | — | $0 | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 8,112 | — | $0 | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 18,550 | — | $0 | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | $0 | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 175,345 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | $0 | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | $0 | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | $0 | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | $0 | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 110,665 | — | $0 | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | $0 | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | $0 | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | $0 | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | $0 | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | $0 | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | $0 | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | $0 | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 150,000 | — | $0 | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 47,758 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 6,743,321 | — | $0 | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer | 2026-09-03 | 2026-09-03 | 1,750,000 | $135.11 | $236.44M | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | D To issuer | 2026-09-03 | 2026-09-03 | 920,941 | — | $0 | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer | 2026-09-03 | 2026-09-03 | 158,371 | — | $0 | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer | 2026-09-03 | 2026-09-03 | 34,824 | — | $0 | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer | 2026-09-03 | 2026-09-03 | 167,123 | — | $0 | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer | 2026-09-03 | 2026-09-03 | 34,824 | — | $0 | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer | 2026-09-03 | 2026-09-03 | 20,000 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer | 2026-09-03 | 2026-09-03 | 51,166 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer | 2026-09-03 | 2026-09-03 | 340,855 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer | 2026-09-03 | 2026-09-03 | 51,166 | — | $0 | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | — | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | — | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | — | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 150,000 | — | — | 0 | SEC↗ |
| McKenna Mark C. | Director | D To issuer | 2026-09-03 | 2026-09-03 | 20,000 | — | — | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | — | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | — | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | — | 0 | SEC↗ |
| JONES WILLIAM A JR | Director | D To issuer | 2026-09-03 | 2026-09-03 | 34,824 | — | — | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | — | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | — | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 110,665 | — | — | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer | 2026-09-03 | 2026-09-03 | 167,123 | — | — | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | — | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | — | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | — | 0 | SEC↗ |
| Fox Jennifer A. | Director | D To issuer | 2026-09-03 | 2026-09-03 | 34,824 | — | — | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 83,690 | — | — | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 124,962 | — | — | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer deriv | 2026-09-03 | 2026-09-03 | 175,345 | — | — | 0 | SEC↗ |
| Henderson Jane | Chief Financial Officer | D To issuer | 2026-09-03 | 2026-09-03 | 158,371 | — | — | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | — | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | — | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 8,112 | — | — | 0 | SEC↗ |
| Bollinger Lisa | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 18,550 | — | — | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer, Dir | D To issuer deriv | 2026-09-03 | 2026-09-03 | 253,016 | — | — | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer, Dir | D To issuer deriv | 2026-09-03 | 2026-09-03 | 357,036 | — | — | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer, Dir | D To issuer deriv | 2026-09-03 | 2026-09-03 | 387,012 | — | — | 0 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer, Dir | D To issuer | 2026-09-03 | 2026-09-03 | 920,941 | — | — | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 365,853 | — | — | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | — | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | — | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | — | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 47,758 | — | — | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 6,743,321 | $135.11 | $911.09M | 0 | SEC↗ |
| Shah Nimish P | Director | D To issuer | 2026-09-03 | 2026-09-03 | 1,750,000 | $135.11 | $236.44M | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | — | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | — | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | — | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 47,758 | — | — | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer deriv | 2026-09-03 | 2026-09-03 | 6,743,321 | — | — | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer | 2026-09-03 | 2026-09-03 | 51,166 | — | — | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer | 2026-09-03 | 2026-09-03 | 51,166 | — | — | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | D To issuer | 2026-09-03 | 2026-09-03 | 340,855 | — | — | 0 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer | 2026-09-02 | 2026-09-03 | 1,375 | $135.06 | $185.7K | 167,123 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | D To issuer | 2026-09-02 | 2026-09-03 | 1,375 | $135.06 | $185.7K | 167,123 | SEC↗ |
| Fairmount Healthcare Fund II L | Director | M Exercise deriv | 2026-08-07 | 2026-08-11 | 10,370 | — | $0 | 0 | SEC↗ |
| Fairmount Healthcare Fund II L | Director | M Exercise deriv | 2026-08-07 | 2026-08-11 | 31,838 | — | $0 | 0 | SEC↗ |
| Fairmount Healthcare Fund II L | Director | M Exercise | 2026-08-07 | 2026-08-11 | 10,370 | $43.85 | $454.7K | 340,855 | SEC↗ |
| Fairmount Healthcare Fund II L | Director | M Exercise | 2026-08-07 | 2026-08-11 | 31,838 | $17.00 | $541.2K | 330,485 | SEC↗ |
| Fairmount Funds Management LLC | Director | M Exercise deriv | 2026-08-07 | 2026-08-11 | 10,370 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | M Exercise deriv | 2026-08-07 | 2026-08-11 | 31,838 | — | $0 | 0 | SEC↗ |
| Fairmount Funds Management LLC | Director | M Exercise | 2026-08-07 | 2026-08-11 | 10,370 | $43.85 | $454.7K | 340,855 | SEC↗ |
| Fairmount Funds Management LLC | Director | M Exercise | 2026-08-07 | 2026-08-11 | 31,838 | $17.00 | $541.2K | 330,485 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-08-05 | 2026-08-07 | 4,125 | — | $0 | 110,665 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-08-05 | 2026-08-07 | 5,500 | $134.17 | $737.9K | 168,498 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-08-05 | 2026-08-07 | 4,125 | $22.86 | $94.3K | 173,998 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-08-05 | 2026-08-07 | 4,125 | — | $0 | 110,665 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-08-05 | 2026-08-07 | 5,500 | $134.17 | $737.9K | 168,498 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-08-05 | 2026-08-07 | 4,125 | $22.86 | $94.3K | 173,998 | SEC↗ |
| Henderson Jane | Chief Financial Officer | G Gift | 2026-07-24 | 2026-07-24 | 15,000 | — | $0 | 158,371 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | G Gift | 2026-07-14 | 2026-07-16 | 8,000 | — | $0 | 169,873 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | G Gift | 2026-07-10 | 2026-07-10 | 75,046 | — | $0 | 920,941 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-07-08 | 2026-07-10 | 20,000 | $133.63 | $2.67M | 995,987 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-07-01 | 2026-07-02 | 4,125 | — | $0 | 114,790 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-07-01 | 2026-07-02 | 4,125 | $22.86 | $94.3K | 183,373 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-07-01 | 2026-07-02 | 5,500 | $132.74 | $730.1K | 177,873 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-06-22 | 2026-06-24 | 80,000 | $132.54 | $10.60M | 1,015,987 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-06-22 | 2026-06-24 | 26,400 | $132.60 | $3.50M | 179,248 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-06-10 | 2026-06-12 | 614 | $86.89 | $53.4K | 1,095,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-06-10 | 2026-06-12 | 2,305 | $86.27 | $198.9K | 1,096,601 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-06-10 | 2026-06-12 | 1,577 | $85.19 | $134.3K | 1,098,906 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-06-10 | 2026-06-12 | 6,770 | $82.21 | $556.6K | 1,109,217 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-06-10 | 2026-06-12 | 1,080 | $84.18 | $90.9K | 1,100,483 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-06-10 | 2026-06-12 | 7,654 | $82.78 | $633.6K | 1,101,563 | SEC↗ |
| Bollinger Lisa | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 7,657 | — | $0 | 7,657 | SEC↗ |
| Fox Jennifer A. | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 7,657 | — | $0 | 7,657 | SEC↗ |
| JONES WILLIAM A JR | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 7,657 | — | $0 | 7,657 | SEC↗ |
| McKenna Mark C. | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 7,657 | — | $0 | 7,657 | SEC↗ |
| Shah Nimish P | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 7,657 | — | $0 | 7,657 | SEC↗ |
| Kiselak Tomas | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 7,657 | — | $0 | 7,657 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-06-03 | 2026-06-05 | 4,125 | — | $0 | 118,915 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-06-03 | 2026-06-05 | 5,500 | $78.71 | $432.9K | 205,648 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-06-03 | 2026-06-05 | 4,125 | $22.86 | $94.3K | 211,148 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-05-13 | 2026-05-15 | 1,341 | $82.58 | $110.7K | 1,115,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-05-13 | 2026-05-15 | 18,659 | $82.05 | $1.53M | 1,117,328 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-05-06 | 2026-05-08 | 4,125 | — | $0 | 123,040 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-08 | 3,700 | $83.92 | $310.5K | 208,823 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-05-06 | 2026-05-08 | 4,125 | $22.86 | $94.3K | 212,523 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-05-06 | 2026-05-08 | 1,800 | $84.60 | $152.3K | 207,023 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-05-01 | 2026-05-04 | 900 | $82.60 | $74.3K | 173,660 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-05-01 | 2026-05-04 | 811 | $81.02 | $65.7K | 174,560 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-05-01 | 2026-05-04 | 289 | $83.16 | $24.0K | 173,371 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | M Exercise deriv | 2026-04-16 | 2026-04-20 | 3,000 | — | $0 | 387,012 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-04-16 | 2026-04-17 | 2,000 | $90.00 | $180.0K | 175,371 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | M Exercise | 2026-04-16 | 2026-04-20 | 3,000 | $22.86 | $68.6K | 1,135,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-04-08 | 2026-04-10 | 17,800 | $82.48 | $1.47M | 1,135,187 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-04-08 | 2026-04-10 | 200 | $85.00 | $17.0K | 1,132,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-04-08 | 2026-04-10 | 2,000 | $83.26 | $166.5K | 1,133,187 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-04-01 | 2026-04-03 | 4,125 | — | $0 | 127,165 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-04-01 | 2026-04-03 | 1,100 | $85.46 | $94.0K | 177,371 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-04-01 | 2026-04-03 | 900 | $84.46 | $76.0K | 178,471 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-04-01 | 2026-04-03 | 4,125 | $22.86 | $94.3K | 213,898 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-04-01 | 2026-04-03 | 100 | $85.89 | $8.6K | 208,398 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-04-01 | 2026-04-03 | 2,702 | $85.33 | $230.6K | 208,498 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-04-01 | 2026-04-03 | 2,698 | $84.31 | $227.5K | 211,200 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-03-25 | 2026-03-27 | 2,000 | $85.00 | $170.0K | 179,371 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-03-11 | 2026-03-13 | 8,363 | $74.29 | $621.3K | 1,164,624 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-03-11 | 2026-03-13 | 8,219 | $74.83 | $615.0K | 1,156,405 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-03-11 | 2026-03-13 | 3,418 | $75.86 | $259.3K | 1,152,987 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-03-04 | 2026-03-06 | 4,125 | — | $0 | 131,290 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-03-04 | 2026-03-06 | 200 | $73.26 | $14.7K | 209,773 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-03-04 | 2026-03-06 | 4,125 | $22.86 | $94.3K | 215,273 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-03-04 | 2026-03-06 | 3,225 | $70.33 | $226.8K | 212,048 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-03-04 | 2026-03-06 | 2,075 | $71.98 | $149.4K | 209,973 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-04 | 406 | $71.66 | $29.1K | 181,371 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-04 | 300 | $68.27 | $20.5K | 183,071 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-04 | 994 | $70.45 | $70.0K | 181,777 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-03-02 | 2026-03-04 | 300 | $69.43 | $20.8K | 182,771 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-02-11 | 2026-02-13 | 7,551 | $63.73 | $481.2K | 1,173,942 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-02-11 | 2026-02-13 | 955 | $64.99 | $62.1K | 1,172,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-02-11 | 2026-02-13 | 11,494 | $62.96 | $723.7K | 1,181,493 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-02-04 | 2026-02-04 | 4,125 | — | $0 | 135,415 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-02-04 | 2026-02-04 | 200 | $68.94 | $13.8K | 211,148 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-02-04 | 2026-02-04 | 1,420 | $65.83 | $93.5K | 212,747 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-02-04 | 2026-02-04 | 1,299 | $66.85 | $86.8K | 211,448 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-02-04 | 2026-02-04 | 4,125 | $22.86 | $94.3K | 216,648 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-02-04 | 2026-02-04 | 2,481 | $64.88 | $161.0K | 214,167 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-02-04 | 2026-02-04 | 100 | $67.88 | $6.8K | 211,348 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-02-02 | 2026-02-04 | 100 | $66.89 | $6.7K | 183,371 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-02-02 | 2026-02-04 | 792 | $65.21 | $51.6K | 184,579 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-02-02 | 2026-02-04 | 1,108 | $66.15 | $73.3K | 183,471 | SEC↗ |
| Harwin Peter Evan | Director | S Sale | 2026-01-22 | 2026-01-22 | 1,750,000 | $76.30 | $133.53M | 298,647 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-01-14 | 2026-01-16 | 5,386 | $83.16 | $447.9K | 1,193,457 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-01-14 | 2026-01-16 | 1,440 | $78.64 | $113.2K | 1,211,547 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-01-14 | 2026-01-16 | 470 | $83.79 | $39.4K | 1,192,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-01-14 | 2026-01-16 | 1,854 | $82.41 | $152.8K | 1,198,843 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-01-14 | 2026-01-16 | 2,374 | $81.00 | $192.3K | 1,200,697 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2026-01-14 | 2026-01-16 | 8,476 | $79.82 | $676.6K | 1,203,071 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2026-01-07 | 2026-01-09 | 14,025 | — | $0 | 139,540 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-01-07 | 2026-01-09 | 2,954 | $77.13 | $227.8K | 228,269 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-01-07 | 2026-01-09 | 100 | $80.06 | $8.0K | 212,523 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-01-07 | 2026-01-09 | 826 | $79.04 | $65.3K | 212,623 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2026-01-07 | 2026-01-09 | 14,820 | $77.90 | $1.15M | 213,449 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2026-01-07 | 2026-01-09 | 14,025 | $22.86 | $320.6K | 231,223 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-01-06 | 2026-01-06 | 2,000 | $80.00 | $160.0K | 185,371 | SEC↗ |
| Henderson Jane | Chief Financial Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 83,690 | — | $0 | 83,690 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 253,016 | — | $0 | 253,016 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | A Award deriv | 2026-01-02 | 2026-01-06 | 83,690 | — | $0 | 83,690 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-01-02 | 2026-01-06 | 1,920 | $74.13 | $142.3K | 191,451 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2026-01-02 | 2026-01-06 | 4,080 | $75.20 | $306.8K | 187,371 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2025-12-19 | 2025-12-23 | 1,500 | $80.00 | $120.0K | 193,371 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-12-10 | 2025-12-12 | 560 | $76.58 | $42.9K | 1,212,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-12-10 | 2025-12-12 | 10,005 | $75.79 | $758.3K | 1,213,547 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-12-10 | 2025-12-12 | 9,435 | $74.88 | $706.5K | 1,223,552 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-12-04 | 2025-12-05 | 40,000 | $75.01 | $3.00M | 1,232,987 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2025-12-04 | 2025-12-05 | 1,500 | $75.00 | $112.5K | 194,871 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-12-04 | 2025-12-05 | 10,900 | $75.00 | $817.5K | 271,108 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2025-11-25 | 2025-11-28 | 1,500 | $70.00 | $105.0K | 196,371 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2025-11-14 | 2025-11-14 | 2,000 | $65.00 | $130.0K | 197,871 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-11-13 | 2025-11-13 | 100 | $64.52 | $6.5K | 1,272,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-11-13 | 2025-11-13 | 1,786 | $63.89 | $114.1K | 1,273,087 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-11-13 | 2025-11-13 | 14,774 | $63.14 | $932.8K | 1,274,873 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-11-13 | 2025-11-13 | 3,340 | $61.93 | $206.8K | 1,289,647 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2025-11-11 | 2025-11-13 | 1,000 | $60.00 | $60.0K | 199,871 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2025-11-05 | 2025-11-07 | 8,060 | — | $0 | 153,565 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-11-05 | 2025-11-07 | 678 | $56.51 | $38.3K | 282,008 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-11-05 | 2025-11-07 | 5,607 | $55.58 | $311.6K | 282,686 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2025-11-05 | 2025-11-07 | 8,060 | $22.86 | $184.3K | 292,793 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-11-05 | 2025-11-07 | 2,300 | $53.62 | $123.3K | 290,493 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-11-05 | 2025-11-07 | 2,200 | $54.83 | $120.6K | 288,293 | SEC↗ |
| Shah Nimish P | Director | P Buy deriv | 2025-10-10 | 2025-10-15 | 365,853 | $41.00 | $15.00M | 365,853 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2025-10-01 | 2025-10-03 | 2,385 | — | $0 | 161,625 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2025-10-01 | 2025-10-03 | 2,385 | $22.86 | $54.5K | 289,843 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-10-01 | 2025-10-03 | 5,110 | $39.80 | $203.4K | 284,733 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-09-03 | 2025-09-05 | 2,535 | $37.82 | $95.9K | 233,738 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-09-03 | 2025-09-05 | 190 | $38.55 | $7.3K | 233,548 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-08-06 | 2025-08-08 | 2,725 | $37.78 | $103.0K | 236,273 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2025-07-02 | 2025-07-03 | 7,365 | — | $0 | 164,010 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-07-02 | 2025-07-03 | 746 | $46.26 | $34.5K | 238,998 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-07-02 | 2025-07-03 | 2,935 | $45.49 | $133.5K | 239,744 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-07-02 | 2025-07-03 | 6,409 | $44.77 | $286.9K | 242,679 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2025-07-02 | 2025-07-03 | 7,365 | $22.86 | $168.4K | 249,088 | SEC↗ |
| Bollinger Lisa | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| Fox Jennifer A. | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| Gottesdiener Andrew | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| JONES WILLIAM A JR | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| McKenna Mark C. | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| Shah Nimish P | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| Fairmount Funds Management LLC | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| Fairmount Funds Management LLC | Director | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-06-04 | 2025-06-06 | 2,725 | $36.96 | $100.7K | 241,723 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-05-07 | 2025-05-09 | 2,725 | $35.75 | $97.4K | 244,448 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-04-02 | 2025-04-04 | 500 | $37.03 | $18.5K | 248,062 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-04-02 | 2025-04-04 | 2,471 | $35.56 | $87.9K | 248,562 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-04-02 | 2025-04-04 | 889 | $37.59 | $33.4K | 247,173 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-03-05 | 2025-03-07 | 7,326 | $29.98 | $219.6K | 1,295,661 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-03-05 | 2025-03-07 | 2,674 | $30.62 | $81.9K | 1,292,987 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-03-05 | 2025-03-07 | 1,590 | $30.48 | $48.5K | 251,033 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2025-02-05 | 2025-02-07 | 795 | — | $0 | 171,375 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-02-05 | 2025-02-07 | 15,000 | $40.58 | $608.7K | 1,302,987 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2025-02-05 | 2025-02-07 | 795 | $22.86 | $18.2K | 256,143 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-02-05 | 2025-02-07 | 3,520 | $40.69 | $143.2K | 252,623 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | M Exercise deriv | 2025-01-31 | 2025-01-31 | 8,500 | — | $0 | 390,012 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | M Exercise | 2025-01-31 | 2025-01-31 | 8,500 | $22.86 | $194.3K | 1,317,987 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-01-08 | 2025-01-10 | 2,868 | $49.38 | $141.6K | 1,309,487 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2025-01-08 | 2025-01-10 | 12,132 | $48.72 | $591.1K | 1,312,355 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2025-01-02 | 2025-01-03 | 1,360 | — | $0 | 172,170 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-01-02 | 2025-01-03 | 2,486 | $47.21 | $117.4K | 255,448 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-01-02 | 2025-01-03 | 1,499 | $46.42 | $69.6K | 257,934 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2025-01-02 | 2025-01-03 | 1,360 | $22.86 | $31.1K | 259,433 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2025-01-02 | 2025-01-03 | 100 | $47.92 | $4.8K | 255,348 | SEC↗ |
| McKenna Mark C. | Director | P Buy | 2024-12-12 | 2024-12-16 | 7,500 | $49.02 | $367.6K | 7,500 | SEC↗ |
| McKenna Mark C. | Director | P Buy | 2024-12-12 | 2024-12-16 | 12,500 | $49.85 | $623.1K | 20,000 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise deriv | 2024-12-11 | 2024-12-13 | 1,815 | — | $0 | 173,530 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | M Exercise | 2024-12-11 | 2024-12-13 | 1,815 | $22.86 | $41.5K | 262,613 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-12-11 | 2024-12-13 | 455 | $50.00 | $22.8K | 258,073 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-12-11 | 2024-12-13 | 4,085 | $48.62 | $198.6K | 258,528 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | A Award deriv | 2024-12-09 | 2024-12-11 | 124,962 | — | $0 | 124,962 | SEC↗ |
| Henderson Jane | Chief Financial Officer | A Award deriv | 2024-12-09 | 2024-12-11 | 124,962 | — | $0 | 124,962 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | A Award deriv | 2024-12-09 | 2024-12-11 | 357,036 | — | $0 | 357,036 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-12-04 | 2024-12-06 | 13,328 | $46.50 | $619.8K | 1,326,159 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-12-04 | 2024-12-06 | 1,672 | $47.19 | $78.9K | 1,324,487 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-12-04 | 2024-12-06 | 6,665 | $46.07 | $307.1K | 260,798 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-11-06 | 2024-11-08 | 1,000 | $59.94 | $59.9K | 1,339,487 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-11-06 | 2024-11-08 | 14,000 | $59.17 | $828.4K | 1,340,487 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-11-06 | 2024-11-08 | 1,339 | $59.96 | $80.3K | 267,463 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-11-06 | 2024-11-08 | 5,326 | $58.91 | $313.8K | 268,802 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-10-02 | 2024-10-04 | 9,712 | $56.74 | $551.1K | 1,354,487 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-10-02 | 2024-10-04 | 30,288 | $56.07 | $1.70M | 1,364,199 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-10-02 | 2024-10-04 | 925 | $56.86 | $52.6K | 274,128 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-10-02 | 2024-10-04 | 5,740 | $56.16 | $322.4K | 275,053 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-09-04 | 2024-09-06 | 14,359 | $48.23 | $692.5K | 1,394,487 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-09-04 | 2024-09-06 | 25,641 | $47.28 | $1.21M | 1,408,846 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-09-04 | 2024-09-06 | 787 | $48.06 | $37.8K | 280,793 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-09-04 | 2024-09-06 | 5,878 | $47.49 | $279.1K | 281,580 | SEC↗ |
| Henderson Jane | Chief Financial Officer | S Sale | 2024-08-23 | 2024-08-23 | 6,000 | $48.26 | $289.6K | 200,871 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-08-07 | 2024-08-09 | 32,233 | $40.40 | $1.30M | 1,442,254 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-08-07 | 2024-08-09 | 7,667 | $41.52 | $318.3K | 1,434,587 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-08-07 | 2024-08-09 | 100 | $42.17 | $4.2K | 1,434,487 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-08-07 | 2024-08-09 | 142 | $41.09 | $5.8K | 288,128 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-08-07 | 2024-08-09 | 6,523 | $40.47 | $264.0K | 288,270 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-08-07 | 2024-08-09 | 670 | $42.56 | $28.5K | 287,458 | SEC↗ |
| HENDERSON MICHAEL THOMAS | Chief Executive Officer | S Sale | 2024-07-05 | 2024-07-05 | 15,000 | $37.26 | $558.9K | 1,474,487 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-07-03 | 2024-07-05 | 3,852 | $37.29 | $143.6K | 296,936 | SEC↗ |
| Dambkowski Carl | Chief Medical Officer | S Sale | 2024-07-03 | 2024-07-05 | 2,143 | $38.16 | $81.8K | 294,793 | SEC↗ |
| Harwin Peter Evan | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| Harwin Peter Evan | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| Gottesdiener Andrew | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| Shah Nimish P | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| Fox Jennifer A. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| Bollinger Lisa | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 8,112 | — | $0 | 8,112 | SEC↗ |
| McKenna Mark C. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| JONES WILLIAM A JR | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| Bollinger Lisa | Director | A Award deriv | 2024-05-28 | 2024-05-30 | 18,550 | — | $0 | 18,550 | SEC↗ |
| Harwin Peter Evan | Director | J Other deriv | 2024-03-28 | 2024-04-01 | 221,426 | — | $0 | 6,743,321 | SEC↗ |